Study finds adults with blood cancer respond to booster dose of COVID-19 vaccination rather than first dose – Times of India
WASHINGTON: Less than half of patients with hematologic malignancies developed detectable antibodies after initial COVID-19 vaccination, but 56 percent of “non-responders” developed antibodies after receiving a booster dose, according to a recent study. . The research findings were published in the journal Cancer. for study, Thomas OlillaBrown University MD, and colleagues retrospectively analyzed antibody responses … Read more